Comparison of Tiotropium Inhalation Capsules and Atrovent Metered Dose Inhaler (MDI) in a Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary Disease

NCT02172443 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: tiotropium inhalation powder capsules
DRUG: Atrovent
DRUG: placebo to Atrovent
DRUG: placebo to tiotropium inhalation capsules

Sponsor

Boehringer Ingelheim